NicOx successfully completes its right issue, raising €100 million following a two-step capital increase
Nicox resubmits AC-170 NDA after API supplier resolves GMP issues
Nicox and Ocumension broaden two agreements in South East Asia
Visible Science
Nicox Reports Fourth Quarter 2021 and Full-Year Revenue Slump
Nicox | LinkedIn
Ophtalmologie : Nicox lève 10M€ - Invest in Côte d'Azur
Nicox Company Profile: Stock Performance & Earnings | PitchBook
Nicox glaucoma drug hits endpoint but falls short of peak performance | BioWorld
Nicox Provides First Quarter 2023 Financial and Business Highlights
NICOX SA : Cours Action Bourse | NXOA | FR0013018124 | Zonebourse
Nicox to Present at Upcoming Scientific Conferences
Bryan, Garnier & Co announces the successful €18m Private Placement of Nicox - Bryan, Garnier & Co
Nicox S.A - Stock and Shares News | IPO HUB
Portal Hypertension in the 21st Century: The proceedings of a symposium sponsored by Axcan Pharma Inc. and NicOx S.A., held in Montrél, Canada, April 2–4, 2004: Groszmann, R.J., Bosch, J.: 9789401037747: Amazon.com: Books
0,561/0,565) Nicox S.A.
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants
NicOx and TOPIGEN Pharmaceuticals terminate collaboration following the acquisition of TOPIGEN by Pharmaxis
Nicox Stock Forecast: down to 0.000001 USD? - NICXF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
NICOX SA: quotazioni Borsa Azione | ALCOX | FR0013018124 | MarketScreener
Visible Science
Nicox Stock Forecast: down to 0.000001 USD? - NICXF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Nicox: 2023 Ordinary Shareholder Meeting
ALCOX Stock Price and Chart — EURONEXT:ALCOX — TradingView
Catalog produse Nicox Pharma
